Add Yahoo as a preferred source to see more of our stories on Google. Thomas Kraut was told he was just fat until doctors discovered a massive tumor in his belly. Doctors were convinced that a ...

“Tumor” rhymes with “humor,” but there is nothing funny about the suffering of the patients seen on TLC’s new real-life medical series “Take My Tumor.” Comedic? Of course not. Nevertheless, the title ...

Tenosynovial giant cell tumor (TGCT) is a group of rare tumors. They are usually benign (not cancer) and tend to occur in people between 25 to 50 years old. The tumors affect areas of the joints and ...

For all the advances in medicine, brain surgery remains a surprisingly barbaric process. I got to learn this firsthand. In March 2023, just before my 40th birthday, I suffered a seizure while out ...

Emactuzumab has received FDA fast track designation for TGCT treatment, aiding development for conditions lacking effective options. The phase 3 TANGENT trial evaluates emactuzumab, a CSF-1R ...

CHICAGO -- An oral investigational agent effectively shrank tenosynovial giant cell tumors (TGCTs) while demonstrating functional and symptomatic benefits for patients, the phase III MOTION trial ...

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue that ...

The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult patients with symptomatic tenosynovial giant cell tumors (TGCT) who will not ...

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza TM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue ...

A research team from Shanghai Jiao Tong University School of Medicine has developed an innovative surgical technique — known as FENCY ligation — combined with preoperative embolization to improve the ...